ABIOMED INC
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $1.03B | $847.5M | $840.9M | $769.4M | $593.7M | $445.3M |
| Operating income | $140.7M | $229.6M | $249.2M | $224.8M | $157.1M | $90.1M |
| Net income | $136.5M | $225.5M | $203.0M | $259.0M | $112.2M | $52.1M |
| Total assets | $1.67B | $1.49B | $1.22B | $1.05B | $786.4M | $550.4M |
| Total liabilities | $170.1M | $164.7M | $151.0M | $117.5M | $96.9M | $98.3M |
| Equity | $1.50B | $1.33B | $1.07B | $936.9M | $689.5M | $452.1M |
| EPS (diluted) | $2.98 | $4.94 | $4.43 | $5.61 | $2.45 | $1.17 |
| Shares out. | 45.6M | 45.3M | 45.0M | 45.1M | 44.5M | 43.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- 13.6%
- Net margin
- 13.2%
- Return on equity
- 9.1%
- Return on assets
- 8.2%
- Return on capital (ROCE)
- 9.2%
- Liabilities / assets
- 10.2%
- Debt / equity
- 0.11×
- Book value / share
- $32.99
- Revenue growth (YoY)
- 21.7%
- Net income growth (YoY)
- −39.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- 15.01safe
- Accruals / assets
- −8.9%clean
- Beneish M-Score
- -2.97normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Sutter Martin PDirector | Dec 22, 2022 | D | 123,370 | — |
| Puhy Dorothy EDirector | Dec 22, 2022 | D | 3,255 | $0.00 |
| Trapp Todd AOfficer — VICE PRESIDENT, CFO | Dec 22, 2022 | D | 14,166 | — |
| Plano Matthew T.Officer — VP, GLOBAL OPERATIONS | Dec 22, 2022 | D | 8,406 | $0.00 |
| Minogue Michael ROfficer — CHAIRMAN, PRESIDENT, CEO | Dec 22, 2022 | D | 166,670 | $0.00 |
| Greenfield Andrew JOfficer — VP, CHIEF COMMERCIAL OFFICER | Dec 22, 2022 | D | 23,484 | $0.00 |
| Began Marc AOfficer — VP & GENERAL COUNSEL | Dec 22, 2022 | D | 12,237 | — |
| Johnson Paula ADirector | Dec 22, 2022 | D | 1,659 | $0.00 |
| Rivet Jeannine MDirector | Aug 10, 2022 | Grant | 9,285 | — |
| Thomas PaulDirector | Dec 22, 2022 | D | 6,357 | — |
| Rolle Myron LDirector | Dec 22, 2022 | D | 1,721 | $0.00 |
| Van Gorder ChrisDirector | Dec 22, 2022 | Grant | 7,410 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsDec 22, 2022
- Results of operationsNov 1, 2022
- Entered a material agreement · Director / officer change · Amended charter or bylaws · Regulation FD disclosureNov 1, 2022
- Shareholder voteAug 12, 2022
- Results of operationsAug 4, 2022
- Other material eventJun 21, 2022
- Results of operationsApr 28, 2022
- Director / officer changeApr 1, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.